Families, lawmakers demand transparency for $89,000 drug
Story highlights A drug for muscular dystrophy has faced criticism for its $89,000-a-year price tag The pharmaceutical company halted its rollout and released a statement justifying the cost CNN — A newly US-approved drug with an $89,000-a-year price tag has Continue reading Families, lawmakers demand transparency for $89,000 drug